本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Lexaria Bioscience Corp

0.7450
+0.01341.83%
成交量:12.61萬
成交額:9.24萬
市值:1,854.11萬
市盈率:-1.32
高:0.7600
開:0.7300
低:0.6900
收:0.7316
52周最高:1.90
52周最低:0.4600
股本:2,488.74萬
流通股本:2,345.37萬
量比:1.00
換手率:0.54%
股息:- -
股息率:- -
每股收益(TTM):-0.5629
每股收益(LYR):-0.6613
淨資產收益率:-155.23%
總資產收益率:-82.96%
市淨率:3.77
市盈率(LYR):-1.13

資料載入中...

2026/02/06

重要事件披露

Form 8-K - Current report
2026/01/28

重要事件披露

Form 8-K - Current report
2026/01/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/01/14

交易所摘牌聲明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2026/01/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/12/17

重要事件披露

Form 8-K - Current report
2025/12/05

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/11/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/10/14

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/09/29

重要事件披露

Form 8-K - Current report
2025/09/25

重要事件披露

Form 8-K - Current report
2025/07/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/06/13

重要事件披露

Form 8-K - Current report
2025/04/28

重要事件披露

Form 8-K - Current report
2025/04/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/02/05

重要事件披露

Form 8-K - Current report
2025/01/28

SEC問詢函

Form CORRESP - Correspondence
2025/01/15

重要事件披露

Form 8-K - Current report
2025/01/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/01/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans